Harmony Biosciences Holdings, Inc. (HRMY)
27.72
-0.09
(-0.32%)
USD |
NASDAQ |
Mar 20, 16:00
28.17
+0.45
(+1.62%)
After-Hours: 20:00
Harmony Biosciences Holdings Market Cap : 1.603B for March 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Castle Biosciences, Inc. | 743.28M |
| BioMarin Pharmaceutical, Inc. | 10.41B |
| Amicus Therapeutics, Inc. | 4.531B |
| Iovance Biotherapeutics, Inc. | 1.520B |
| Apellis Pharmaceuticals, Inc. | 2.200B |
Market Cap Related Metrics
| PE Ratio | 10.23 |
| PS Ratio | 1.870 |
| PEG Ratio | 1.293 |
| Price to Book Value | 1.842 |
| Price to Free Cash Flow | 4.942 |
| Price | 27.72 |
| Earnings Yield | 9.77% |
| PEGY Ratio | 1.293 |
| Operating PE Ratio | 7.791 |
| Normalized PE Ratio | 10.23 |